Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Best Practice & Research. Clinical Rheumatology|June 8, 2019
Disease activity assessment in patients with psoriatic arthritisAndreas Kerschbaumer, Josef S Smolen, Daniel Aletaha
Rheumatology (Oxford, England)|June 26, 2026
Detectable safety gestalt of rheumatoid arthritis treatments from pivotal clinical drug trialsVictoria Konzett, Andreas Kerschbaumer, Laurenz Willmann, et al.
Annals of the Rheumatic Diseases|August 25, 2017
The effects of structural damage on functional disability in psoriatic arthritisAndreas Kerschbaumer, Daniel Baker, Josef S Smolen, et al.
Annals of the Rheumatic Diseases|September 27, 2023
Determination of the most appropriate ACR response definition for contemporary drug approval trials in rheumatoid arthritisVictoria Konzett, Andreas Kerschbaumer, Josef S Smolen, et al.
Environmental Monitoring and Assessment|March 2, 2017
Re-construction of the shut-down PM10 monitoring stations for the reliable assessment of PM10 in Berlin using fuzzy modelling and data transformationHamid Taheri Shahraiyni, Sahar Sodoudi, Andreas Kerschbaumer, et al.
Wiener Klinische Wochenschrift|November 9, 2016
An overview of psoriatic arthritis - epidemiology, clinical features, pathophysiology and novel treatment targetsAndreas Kerschbaumer, Karl H Fenzl, Ludwig Erlacher, et al.
Annals of the Rheumatic Diseases|June 20, 2022
Impact of pre-existing background therapy on placebo responses in randomised controlled clinical trials of rheumatoid arthritisAndreas Kerschbaumer, Zaïda Iasha Rivai, Josef S Smolen, et al.
Wiener Klinische Wochenschrift|September 28, 2016
Fever of unknown origin (FUO) revisedManuel Unger, Georgios Karanikas, Andreas Kerschbaumer, et al.
Nature Medicine|April 22, 2020
Efficacy outcomes in phase 2 and phase 3 randomized controlled trials in rheumatologyAndreas Kerschbaumer, Josef S Smolen, Harald Herkner, et al.
Annals of the Rheumatic Diseases|January 10, 2023
Influence of active versus placebo control on treatment responses in randomised controlled trials in rheumatoid arthritisAndreas Kerschbaumer, Nina Maria Stimakovits, Josef S Smolen, et al.
Pageof 6